Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3657-3667
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3657
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3657
Table 2 NAT2 phenotypes and genotypes
| Mutations | Allele designation | Phenotype |
| None | NAT2*4 (wild-type) | normal |
| T341C, C481T, A803G | NAT2*5B (r3,S1a) | Slow |
| C282T, G590A | NAT2*6A (M2) | Slow |
| T341C, C481T | NAT2*5A (M1) | Slow |
| T341C, CA803G | NAT2*5C (S1c) | Slow |
| C282T, G857A | NAT2*7B (M3) | Slow |
| C282T | NAT2*13 (S4) | |
| G590A | NAT2*6B (R2) | Unknown |
| G191A | NAT2*14A (M4) | Slow |
| A803G | NAT2*12A | Rapid |
- Citation: Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006; 12(23): 3657-3667
- URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3657